MBM Wealth Consultants’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,378
Closed -$254K 111
2023
Q2
$254K Sell
8,378
-640
-7% -$20.9K 0.11% 84
2023
Q1
$364K Hold
9,018
0.15% 64
2022
Q4
$335K Buy
9,018
+1,693
+23% +$63.7K 0.16% 67
2022
Q3
$238K Sell
7,325
-693
-9% -$25.7K 0.11% 75
2022
Q2
$304K Sell
8,018
-973
-11% -$41.8K 0.15% 70
2022
Q1
$403K Sell
8,991
-6,503
-42% -$320K 0.17% 69
2021
Q4
$808K Sell
15,494
-12,096
-44% -$586K 0.34% 41
2021
Q3
$1.3M Buy
27,590
+1,026
+4% +$49.5K 0.59% 30
2021
Q2
$1.4M Sell
26,564
-2,242
-8% -$121K 0.66% 27
2021
Q1
$1.58M Buy
28,806
+291
+1% +$14.4K 0.8% 25
2020
Q4
$1.14M Buy
28,515
+28,384
+21,667% +$1.1M 0.62% 30
2020
Q3
$5K Hold
131
﹤0.01% 193
2020
Q2
$6K Hold
131
﹤0.01% 185
2020
Q1
$6K Hold
131
0.01% 170
2019
Q4
$8K Hold
131
0.01% 180
2019
Q3
$7K Hold
131
0.01% 178
2019
Q2
$7K Hold
131
0.01% 181
2019
Q1
$8K Hold
131
0.01% 177
2018
Q4
$9K Buy
+131
New +$10.2K 0.01% 184

Other funds holding WBA

MBM Wealth Consultants's WBA Position: Q3 2023 in Review

MBM Wealth Consultants sold out of Walgreens Boots Alliance (WBA) in Q3 2023, closing a stake of 8,378 shares — an estimated $254K sold.

MBM Wealth Consultants first reported a position in WBA in Q4 2018 and held it in 19 quarters. The position peaked at $1.58M in Q1 2021. 1,046 funds tracked by Wall St. Rank hold WBA as of Q3 2023.

  • MBM Wealth Consultants reported no remaining Walgreens Boots Alliance position as of Q3 2023 after selling out during the quarter.
  • MBM Wealth Consultants sold 8,378 Walgreens Boots Alliance shares in Q3 2023, an estimated $254K.
  • MBM Wealth Consultants first reported a position in Walgreens Boots Alliance in Q4 2018 and held it in 19 quarters.
  • MBM Wealth Consultants's Walgreens Boots Alliance position peaked at $1.58M in Q1 2021.
  • 1,046 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q3 2023.

Based on MBM Wealth Consultants's 13F filing for Q3 2023, filed 19 Oct 2023.